Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 4,443 | 4,339 | 5,111 | 4,502 | 5,694 |
| Operating Income | -4,443 | -4,339 | -5,111 | -4,502 | -5,694 |
| Interest Expense | -320 | 0 | 0 | 0 | 1 |
| Other Income | -42 | 173 | -78 | 1 | -5 |
| Pre-tax Income | -4,165 | -4,166 | -5,189 | -4,501 | -5,700 |
| Net Income Continuous | -4,165 | -4,166 | -5,189 | -4,501 | -5,700 |
| Net Income | $-4,165 | $-4,166 | $-5,189 | $-4,501 | $-5,700 |
| EPS Basic Total Ops | -0.41 | -0.41 | -0.64 | -0.55 | -0.70 |
| EPS Basic Continuous Ops | -0.41 | -0.41 | -0.64 | -0.55 | -0.70 |
| EPS Diluted Total Ops | -0.41 | -0.41 | -0.64 | -0.55 | -0.70 |
| EPS Diluted Continuous Ops | -0.41 | -0.41 | -0.64 | -0.55 | -0.70 |
| EBITDA(a) | $-4,335 | $-4,238 | $-5,008 | $-4,402 | $-5,596 |